Marimed (MRMD) Profit After Tax (2011 - 2026)

Marimed (MRMD) has reported Profit After Tax for 16 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax fell 157.28% year-over-year to -$3.6 million in Q2 2026; TTM through Jun 2026 was -$14.9 million, a 7.51% increase from a year earlier, with the FY2025 full-year figure at -$14.5 million, down 16.18% from the prior year.
• Profit After Tax was -$3.6 million for Q2 2026 at Marimed, up from -$3.8 million in the prior quarter.
• Over five years, Profit After Tax peaked at $4.8 million in Q4 2022 and troughed at -$10.2 million in Q4 2023.
• A 5-year average of -$2.0 million and a median of -$1.6 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax surged 174.32% in 2022 and sank 313.73% in 2023, its largest moves.
• Over 5 years, Profit After Tax stood at $4.8 million in 2022, then slumped by 313.73% to -$10.2 million in 2023, then increased by 18.66% to -$8.3 million in 2024, then surged by 43.98% to -$4.6 million in 2025, then grew by 22.5% to -$3.6 million in 2026.
• The last three Profit After Tax figures came in at -$3.6 million (Q2 2026), -$3.8 million (Q1 2026), and -$4.6 million (Q4 2025), per Business Quant data.